Regional citrate anticoagulation in continuous venovenous haemofiltration using commercial preparations

Nephrology

Volumn 11, Issue 5, 2006, Pages 405-409

  Munjal, Sandeep ^a   Ejaz, A Ahsan ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Anticoagulant citrate dextrose in formula A; Commercial; Continuous venovenous haemofiltration; Solutions

Indexed keywords

CITRIC ACID; GLUCOSE;

ABSENCE OF SIDE EFFECTS; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; BLEEDING; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; REVIEW; SURVIVAL TIME;

ACUTE KIDNEY INJURY; ADULT; AGED; ANTICOAGULANTS; CITRIC ACID; FEMALE; GLUCOSE; HEMOFILTRATION; HUMANS; ISOTONIC SOLUTIONS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33749156722     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00653.x     Document Type: Review

References (25)

1. Kaplan AA, Longnecker RE, Folkert VW. Continuous arteriovenous hemofiltration. A report of six months' experience. Ann. Intern. Med. 1984; 100: 358-67.
2. Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int. 1993; 41: S237-44.
3. Paganini EP. Slow continuous hemofiltration and slow continuous ultrafiltration. ASAIO Trans. 1988; 34: 63-6.
4. Ponikvar R, Kandus A, Buturovic J, Kveder R. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration. Contrib. Nephrol. 1991; 93: 218-20.
5. Ohtake Y, Hirasawa H, Sugai T et al. Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodia-filtration. Contrib. Nephrol. 1991; 93: 215-17.
6. Hory B, Cachoux A, Toulemonde F. Continuous arteriovenous hemofiltration with low-molecular-weight heparin. Nephron 1985; 41: 125.
7. Favre H. Hemodialysis, peritoneal dialysis or continuous extracorporeal epuration in acute renal failure patients. Contrib. Nephrol. 1989; 71: 100-103.
8. Hofbauer R, Moser D, Frass M et al. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int. 1999; 56: 1578-83.
9. Continault O, Kamar N, Bories P et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol. Dial. Transplant. 2004; 19: 171-8.
10. Kutsogiannis DJ, Mayers I, Chin WDN, Gibney RTN. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am. J. Kidney Dis. 2000; 35: 802-11.
11. Lohr JW, Slusher S, Diedrich D. Safety of regional citrate hemodialysis in acute renal failure. Am. J. Kidney Dis. 1989; 13: 104-7.
12. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 1990; 38: 976-81.
13. Ashton DN, Mehta RL, Ward DM, McDonald BR, Aguilar MM. Recent advances in continuous renal replacement therapy: Citrate anticoagulated continuous arteriovenous hemodialysis. ANNA J. 1991; 18: 263-7.
14. Mitchell A, Daul AE, Beiderlinden M et al. A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin. Nephrol. 2003; 59: 106-14.
15. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int. 1999; 55: 1991-7.
16. Cointault O, Kamar N, Bories P et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol. Dial. Transplant. 2004; 19: 171-8.
17. Bunchman TE, Maxvold NJ, Brophy PD. Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am. J. Kidney Dis. 2003; 42: 1248-52.
18. Meier-Kriesche HU, Finkel KW, Gitomer JJ, DuBose TD Jr. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am. J. Kidney Dis. 1999; 33: e8.
19. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med. 2004; 30: 260-65.
20. Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356: 26-30.
21. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int. 2001; 60: 370-74.
22. Hoffman RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren. Fail. 2002; 24: 325-35.
23. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: A metabolic challenge. Intensive Care Med. 2002; 28: 1419-25.
24. Tan HK, Baldwin R, Bellomo R. Continuous venovenous hemo-filtration without anticoagulation in high-risk patients. Intensive Care Med. 2000; 26: 1652-7.
25. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous venovenous hemofiltration without anticoagulation. ASAIO J. 2004; 50: 76-80.